← Back to Search

Behavioral Intervention

Hypnotic Cognitive Therapy for Chronic Pain (HYPCT Trial)

N/A
Waitlist Available
Led By Amy J Starosta, PhD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of SCI at any level or severity
Currently admitted to IPR at Harborview Medical Center
Must not have
Unable to provide informed consent
Severe cognitive impairment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 time upon enrollment, time at 6 month follow-up, 1 time at 7 month follow-up.
Awards & highlights

Summary

This trial will study a new way to reduce chronic pain in people with spinal cord injuries, by comparing Hypnosis Enhanced Cognitive Therapy to Pain Education. Participants will complete surveys and assessment to track the impact of the treatments.

Who is the study for?
This trial is for individuals with a spinal cord injury (SCI) who are experiencing moderately intense pain and can read and speak English. They must be currently admitted to inpatient rehabilitation at Harborview Medical Center. People with severe cognitive issues, significant mental health conditions, or recent suicidal behaviors cannot participate.
What is being tested?
The study compares Hypnosis Enhanced Cognitive Therapy (HYPCT) with Pain Education (ED) to see which is better at reducing acute and chronic pain in SCI patients during inpatient rehab. Participants will complete surveys and pain assessments before and after four sessions of either HYPCT or ED.
What are the potential side effects?
Since the interventions are non-medical, major side effects are not expected. However, some participants might experience discomfort related to discussing their pain or engaging in therapy sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with a spinal cord injury.
Select...
I am currently a patient at Harborview Medical Center.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am unable to understand and agree to the study's details on my own.
Select...
I have significant memory or thinking problems.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 time upon enrollment, time at 6 month follow-up, 1 time at 7 month follow-up.
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 time upon enrollment, time at 6 month follow-up, 1 time at 7 month follow-up. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
0-10 Numerical Rating Scale of Pain (Pain Relief following Practice Sessions)
0-10 Numerical Rating Scale of Pain (Weekly average pain intensity)
0-10 Numerical Rating Scale of Pain change score (Decrease in Pain following live Session with Therapist)
+2 more
Secondary study objectives
0-10 Numerical Rating Scale of Pain (Pain Relief following Medication Administration)
Digit span (forward, backward, sequencing) (Working memory)
Opioid Use from Electronic medical record review
+5 more
Other study objectives
Benefit, Satisfaction, and Willingness (BSW)
Chronic Pain Acceptance Scale (Pain Acceptance)
Frequency of Independent Practice
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Hypnosis Enhanced Cognitive TherapyExperimental Treatment1 Intervention
This arm will receive 4 sessions of hypnosis enhanced cognitive therapy for pain. Subjects will receive recordings of sessions for practice between therapist sessions.
Group II: Pain EducationActive Control1 Intervention
This arm will receive 4 sessions of spinal cord injury pain education. Subjects will receive pain education materials for review between therapist sessions.

Find a Location

Who is running the clinical trial?

The Craig H. Neilsen FoundationOTHER
58 Previous Clinical Trials
2,904 Total Patients Enrolled
University of WashingtonLead Sponsor
1,791 Previous Clinical Trials
1,905,418 Total Patients Enrolled
Amy J Starosta, PhDPrincipal InvestigatorUniversity of Washington
~44 spots leftby Sep 2025